Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 50

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 50
---
 and the Warrants, please refer to our Current Report on Form 8-K filed with the SEC May 27, 2025. The discussion herein is qualified in its entirety by reference to such filed transaction documents.

Vote Required

The affirmative vote of the holders of a majority of the votes cast affirmatively or negatively for this proposal will be required to approve the Issuance Proposal. Abstentions and broker non-votes will have no effect on the results of the vote on Proposal No. 4.

<div align='center'>THE BOARD UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE ISSUANCE PROPOSAL</div>

| 41 |

<div align='center'>PROPOSAL NO. 5:

APPROVAL OF THE AUTHORIZED SHARE INCREASE PROPOSAL</div>

Our Board has approved, subject to stockholder approval, an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 112,500,000 to 350,000,000 and to make a corresponding change to the number of authorized shares of capital stock. The form of this proposed certificate of amendment to the Amended and Restated Certificate of Incorporation (the “Authorized Share Increase Amendment”) is attached to this Proxy Statement as an exhibit. We currently have a total of 112,600,000 shares of capital stock authorized under our Amended and Restated Certificate of Incorporation, consisting of 112,500,000 shares of common stock and 100,000 shares of preferred stock. If the Authorized Share Increase proposal is approved by our stockholders, our Board of Directors will be authorized, in its discretion, to file the Authorized Share Increase Amendment with the office of the Secretary of State of the State of Delaware, which would have the effect of increasing the number of authorized shares of common stock from 112,500,000 to 350,000,000 and increasing the number of authorized shares of all classes of stock from 112,600,000 to 350,100,000. The number of shares of authorized preferred stock would remain unchanged. Each additional authorized share of common stock would have the same rights and privileges as each share of currently authorized common stock.

Reasons for the Authorized Share Increase

Our Board of Directors believes it to be in our best interests to have sufficient additional authorized but unissued shares of common stock available in order to provide flexibility for corporate action in the future. Management believes that the availability